Neutrophil-Integrated Syncytial CAR Macrophages Show Promise for Cancer Immunotherapy
Cancer immunotherapy has gained a hybrid new contender: a living cell engineered by fusing two immune-system specialists into one tumor-hunting ...
Cancer immunotherapy has gained a hybrid new contender: a living cell engineered by fusing two immune-system specialists into one tumor-hunting ...
Cancer immunotherapy is entering a more controlled and technically sophisticated phase, according to a wide-ranging collection of studies and reviews ...
Mass General Brigham researchers have identified two genetic regulators that appear to drive the decline of cancer-fighting T cells in ...
Researchers at Purdue University have developed a small-molecule compound that could open a new route toward cancer immunotherapy by targeting ...
Zhou, Fiches, Wu and colleagues report that blocking the chromatin-regulating enzymes KDM5A and KDM5B can strengthen antitumor innate immune responses ...
Irvine, Calif., Aug. 20, 2026 — Immunotherapy has changed the outlook for many people with advanced cancer by turning the ...
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified a potential way ...
Colorectal cancer has become a proving ground for a new generation of cancer treatments, but one of the most promising ...
For years, CAR-T cell therapy has stood as one of cancer medicine’s most striking successes. By removing a patient’s T ...
Personalized cancer vaccines are moving from an experimental promise toward a more structured form of immunotherapy, but the field still ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine